|
Sign In to gain access to subscriptions and/or personal tools.
|
Volatile Anesthetics and Cardiac Function
Stefan G. De Hert, MD, PhD
Department of Anesthesiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium; stefan.dehert{at}ua.ac.be
All volatile anesthetics have been shown to induce a dose-dependent decrease in myocardial contractility and cardiac loading conditions. These depressant effects decrease myocardial oxygen demand and may, therefore, have a beneficial role on the myocardial oxygen balance during myocardial ischemia. Recently, experimental evidence has clearly demonstrated that in addition to theseindirect protective effects, volatile anesthetic agents also havedirect protective properties against reversible and irreversible ischemic myocardial damage. These properties have not only been related to a direct preconditioning effect but also to an effect on the extent of reperfusion injury. The implementation of these properties during clinical anesthesia can provide an additional tool in the treatment or prevention, or both, of ischemic cardiac dysfunction in the perioperative period. In the clinical practice, these effects should be associated with improved cardiac function, finally resulting in a better outcome in patients with coronary artery disease. The potential application of these protective properties of volatile anesthetic agents in clinical practice is the subject of ongoing research. This review summarizes the current knowledge on this subject.
References
- De Hert SG, Van der Linden PJ, ten Broecke PW, et al: Effects of desflurane and sevoflurane on length-dependent regulation of myocardial function in coronary surgery patients. Anesthesiology 95:357-363, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sommerschild HT, Kirkeboen KA: Preconditioningendogenous defence mechanisms of the heart. Acta Anaesth Scand 46:123-137, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tanaka K, Ludwig LM, Kersten JR, et al: Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 100:707-721, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- De Hert SG, Turani F, Mathur S, et al: Cardioprotection with volatile anaesthetics: Mechanisms and clinical implications. Anesth Analg 100:1584-1593, 2005.[Abstract/Free Full Text]
- Tuman KJ, McCarthy RJ, Spiess BD, et al: Does choice of anesthetic agent significantly affect outcome after coronary surgery? Anesthesiology 70:189-198, 1989.[Web of Science][Medline]
[Order article via Infotrieve]
- Belhomme D, Peynet J, Louzy M, et al: Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100:II 340-344, 1999.
- Pouzet B, Lecharny JB, Dehoux M, et al: Is there a place for preconditioning during cardiac operations in humans? Ann Thorac Surg 73:843-848, 2002.[Abstract/Free Full Text]
- Julier K, da Silva R, Garcia C, et al: Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. Anesthesiology 98:1315-1327, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Penta de Peppo A, Polisca P, Tomai F, et al: Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 68:112-118, 1999.[Abstract/Free Full Text]
- Tomai F, De Paulis R, Penta de Peppo A, et al: Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 29:1007-1014, 1999.[Medline]
[Order article via Infotrieve]
- Haroun-Bizri S, Khoury SS, Chehab IR, et al: Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothor Vasc Anesth 15:418-421, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yvon A, Hanouz JL, Haelewyn B, et al: Mechanisms of sevoflurane-induced myocardial preconditioning in isolated human right atria in vitro. Anesthesiology 99:27-33, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nader ND, Li CM, Khadra WZ, et al: Anesthetic myocardial protection with sevoflurane. J Cardiothor Vasc Anesth 18:269-274, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- De Hert SG, ten Broecke PW, Mertens E, et al: Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 97:42-49, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- De Hert SG, Cromheecke S, ten Broecke PW, et al: Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 99:314-323, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Van der Linden PJ, Daper A, De Hert SG. Cardioprotective effects of volatile anesthetics in cardiac surgery. Anesthesiology 99:516-517, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Conzen PF, Fisher S, Detter C, et al: Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 99:826-833, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bein B, Renner J, Caliebe D, et al: Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 100:610-616, 2005.[Abstract/Free Full Text]
- El Azab SR, Rosseel PMJ, De Lange JJ, et al: Effect of sevoflurane on the ex vivo secretion of TNF-a during and after coronary artery bypass surgery. Eur J Anaesthesiol 20:380-384, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- De Hert SG, Van der Linden PJ, Cromheecke S, et al: Choice of the primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 101:9-20,2004.[Web of Science][Medline]
[Order article via Infotrieve]
- De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101:299-310, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cromheecke S, ten Broecke PW, Hendrickx E, et al: Atrial fibrillation after coronary surgery: Can choice of the anesthetic regimen influence the incidence? Acta Anaesthesiol Belg 56:147-154, 2005.[Medline]
[Order article via Infotrieve]
Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 10, No. 1,
33-42 (2006)
DOI: 10.1177/108925320601000107

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|